Showing results (11-20 of 471) with videos related to
Sort By:
Pageof 48
Molecular and Cellular Therapies|June 10, 2015
Outlook on PI3K/AKT/mTOR inhibition in acute leukemiaLars Fransecky, Liliana H Mochmann, Claudia D BaldusReviews in Clinical and Experimental Hematology|July 20, 2005
Genomics in myeloid leukemias: an array of possibilitiesLars Bullinger, Hartmut Döner, Jonathan R PollackMethods in Molecular Biology (Clifton, N.J.)|August 30, 2025
Combination of Long-Read Sequencing and Hi-C Technology to Identify Chromoanagenesis Events in CancerMarius-Konstantin Klever, Julius Jungnitsch, Lars BullingerActa Haematologica|May 26, 2023
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular AnalysisThomas Burmeister, Lars Bullinger, Philipp le CoutreExpert Review of Hematology|March 16, 2018
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemiaStephan R Bohl, Lars Bullinger, Frank G RückerInternational Journal of Molecular Sciences|April 26, 2019
New Targeted Agents in Acute Myeloid Leukemia: New Hope on the RiseStephan R Bohl, Lars Bullinger, Frank G RückerBritish Journal of Haematology|May 10, 2007
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewClaudia D Baldus, Krzysztof Mrózek, Guido Marcucci, et al.Genes|July 2, 2021
Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic CellsMichaela Kotrova, Nikos Darzentas, Christiane Pott, et al.Future Oncology (London, England)|October 6, 2010
DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insightsRainer Claus, Christoph Plass, Scott A Armstrong, et al.Expert Review of Hematology|October 1, 2020
Bispecific antibodies in acute lymphoblastic leukemia therapyGuranda Chitadze, Anna Laqua, Marcus Lettau, et al.Pageof 48